Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.

导出原文传递

翻译打印收藏纠错

作者： Robin M,Turner ^[1] ; Mbathio,Dieng ^[2] ; Nikita,Khanna ^[3] ; Mai,Nguyen ^[3] ; Jiaxu,Zeng ^[4] ; Amanda A G,Nijhuis ^[5] ; Omgo E,Nieweg ^[5] ; Andrew J,Einstein ^[6] ; Louise,Emmett ^[7] ; Sarah J,Lord ^[8] ; Alexander M,Menzies ^[9] ; John F,Thompson ^[3] ; Robyn P M,Saw ^[5] ; Rachael L,Morton ^[6]

作者单位： Centre for Biostatistics, University of Otago, Dunedin, New Zealand. ^[1] NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. mbathio.dieng@sydney.edu.au. ^[2] NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. ^[3] Preventive and Social Medicine, University of Otago, Dunedin, New Zealand. ^[4] Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. ^[5] Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. ^[6] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. ^[7] Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA. ^[8] Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia. ^[9] Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. ^[10]